The Drugs Controller General of India (DCGI) has asked for a clarification from Glenmark Pharmaceuticals regarding its alleged "false claims" on the utilisation of anti-viral FabiFlu (favipiravir) on...
from NDTV News - Latest https://ift.tt/3jjsiDu
Sunday, July 19, 2020
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment